ZMYND8 and neoplasm: In line with the negative regulation of MST1/2 on ZMYND8, this analysis also revealed that the expression levels of ZMYND8 were higher in oxaliplatin-treated tissues than in untreated tumor tissues (Supplemental Figure 8E).